e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk
Beverly B Green, Melissa L Anderson, Andrea J Cook, Sheryl Catz, Paul A Fishman, Jennifer B McClure, Robert J Reid, Beverly B Green, Melissa L Anderson, Andrea J Cook, Sheryl Catz, Paul A Fishman, Jennifer B McClure, Robert J Reid
Abstract
Background: Pharmacist- or nurse-led team care decreases patient blood pressure (BP) and cardiovascular disease (CVD) risk.
Purpose: To evaluate whether a Web-based dietitian-led (WD) team care intervention was feasible and resulted in decreased BP, CVD risk, and weight compared to usual care (UC).
Methods: Electronic health record (EHR) data identified patients aged 30-69 years with BMI >26, elevated BP, and 10%-25% 10-year Framingham CVD risk who were registered patient website users. Patients with uncontrolled BP at screening were randomized to UC or WD, which included a home BP monitor, scale, and dietitian team care. WD participants had a single in-person dietitian visit to obtain baseline information and create a plan to reduce CVD risk. Planned follow-up occurred via secure messaging to report BP, weight, and fruit and vegetable intake and receive ongoing feedback. If needed, dietitians encouraged patients and their physicians to intensify antihypertensive and lipid-lowering medications. Primary outcomes were change in systolic BP and weight loss ≥4 kg at 6 months. Feasibility outcomes included intervention utilization and satisfaction.
Results: Between 2010 and 2011, a total of 90 of 101 participants completed 6-month follow-ups. The WD group had higher rates of secure messaging utilization and patient satisfaction. The WD group lost significantly more weight than the UC group (adjusted net difference=-3.2 kg, 95% CI=-5.0, -1.5, p<0.001) and was more likely to lose ≥4 kg (adjusted relative risk [RRadj]=2.96, 95% CI=1.16, 7.53). BP control and CVD risk reduction were greater in WD than UC, but differences were not statistically significant.
Conclusions: WD intervention was feasible and resulted in decreased weight, BP, and CVD risk. A larger trial is justified.
Trial registration number: Trial Registration Number: NCT01077388.
Copyright © 2014 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures
Source: PubMed
Prochains essais cliniques
-
Shirley Ryan AbilityLabKiwanis Neurological Research FoundationRecrutementTraumatisme crânien TBIÉtats-Unis
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)Pas encore de recrutementThromboembolie veineuse | Chirurgie du pelvis | Chirurgie du cancer de l'abdomenÉtats-Unis
-
Fundacion para la Investigacion Biomedica del Hospital...Hospital Universitario La FeRecrutement
-
Lumetry Diagnostics GmbHKarl Landsteiner Institute for Lung Research and Pneumological Oncology; Klinik...Pas encore de recrutementMaladie pulmonaire obstructive chronique | HypercapnieL'Autriche
-
Beijing Suncadia Pharmaceuticals Co., LtdRecrutementLa maladie d'AlzheimerChine
-
IpsenPas encore de recrutementCancer de la prostate
-
Xiangya Hospital of Central South UniversityPas encore de recrutementPsoriasis en plaques | DyslipidémieChine
-
Halic UniversityPas encore de recrutementQualité du sommeil | Intervention diététique | Stress perçu | Brouillard cérébralTurquie (Türkiye)
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPas encore de recrutementCancer du sein métastatique | Cancer du sein à récepteurs hormonaux positifs | Cancer du sein HER2-faibleChine
-
The 108 Military Central HospitalVietnam Military Medical University; Thanh Phuong Co., LtdPas encore de recrutementChoc septique | Lésion rénale aiguëViêt Nam
-
University Hospital, MontpellierPas encore de recrutementHémiparésie | Spasticité | Spasticité des membres supérieursFrance
-
Kasr El Aini HospitalRecrutementMastite granulomateuse idiopathiqueEgypte
